Chemical inhibitors of FAM164B target various signaling pathways to achieve functional inhibition of the protein. Staurosporine is a potent protein kinase inhibitor that hinders the phosphorylation and activation of FAM164B by blocking the kinase's catalytic activity. Similarly, Bisindolylmaleimide I specifically inhibits Protein Kinase C, which is responsible for phosphorylating proteins including FAM164B, thereby preventing its functional activation. LY294002 and Wortmannin are both inhibitors of PI3K, a key component in the Akt signaling pathway that FAM164B is a part of. By inhibiting PI3K, both chemicals reduce the phosphorylation and subsequent activity of FAM164B. U0126 and PD98059 focus on the MAPK/ERK pathway, where they inhibit MEK1/2, leading to a reduction in the phosphorylation and activity of FAM164B. SB203580 targets the p38 MAP kinase, another enzyme in the signaling cascade involving FAM164B, and its inhibition results in decreased phosphorylation of FAM164B.
In addition to the above, SP600125 inhibits JNK, which is part of the signaling pathways that regulate the activity of FAM164B, leading to its decreased activation. Rapamycin acts by inhibiting mTOR, a regulatory kinase that may control FAM164B activity within the mTOR signaling pathway, thereby achieving inhibition of FAM164B. LFM-A13 targets Bruton's tyrosine kinase, which influences the signaling pathways that FAM164B is implicated in, and inhibition of this kinase reduces the phosphorylation and activity of FAM164B. Gö 6983 inhibits several isoforms of PKC, potentially involved in the phosphorylation of FAM164B, thus reducing its activity. Lastly, PP2 inhibits Src family kinases that are involved in the regulatory pathways affecting FAM164B, and by inhibiting these kinases, PP2 decreases the phosphorylation and overall activity of FAM164B. Each of these chemicals acts through these specific pathways to impede the phosphorylation, activation, or signaling processes that are essential for the normal functioning of FAM164B, leading to its inhibition.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine inhibits protein kinases which are crucial for the phosphorylation and activation of FAM164B, leading to its functional inhibition. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I inhibits Protein Kinase C that is responsible for phosphorylating certain substrates including FAM164B, leading to its functional inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K which plays a role in the Akt signaling pathway, a pathway that FAM164B is involved in. This inhibition can reduce the phosphorylation of FAM164B, leading to its functional inhibition. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits PI3K, reducing the activity of the Akt pathway which FAM164B is involved in, thereby inhibiting the phosphorylation and function of FAM164B. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2 which is involved in the MAPK/ERK pathway, a pathway where FAM164B has a functional role. Inhibition of MEK1/2 leads to a decrease in FAM164B phosphorylation and function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK which is part of the MAPK/ERK pathway that influences the activity of FAM164B. Inhibition of MEK leads to reduced phosphorylation and activity of FAM164B. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAP kinase, which is involved in the same signaling pathway as FAM164B. Inhibition of p38 MAP kinase leads to decreased phosphorylation and subsequent functional inhibition of FAM164B. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which, being part of the signaling pathways that FAM164B is involved in, its inhibition results in decreased activity of FAM164B. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is a kinase that may regulate FAM164B activity as part of the mTOR signaling pathway. Inhibition of mTOR leads to functional inhibition of FAM164B. | ||||||
LFM-A13 | 62004-35-7 | sc-203623 sc-203623A | 10 mg 50 mg | $119.00 $670.00 | ||
LFM-A13 inhibits Bruton's tyrosine kinase, which can regulate signaling pathways involving FAM164B. Inhibition of Btk leads to decreased phosphorylation and activity of FAM164B. | ||||||